These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15795684)

  • 21. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
    Zhang ZJ; Kang WH; Li Q; Tan QR
    J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
    Ketter TA; Kalali AH; Weisler RH;
    J Clin Psychiatry; 2004 May; 65(5):668-73. PubMed ID: 15163253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.
    Greil W; Kleindienst N
    Int Clin Psychopharmacol; 1999 Sep; 14(5):277-81. PubMed ID: 10529070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of antiepileptic drugs in bipolar disorder].
    Pérez-Ceballos MA; Vega-Gil N; Sánchez MB; Armijo JA
    Actas Esp Psiquiatr; 2006; 34(1):55-64. PubMed ID: 16525906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():19-22. PubMed ID: 16754408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of anticonvulsants in the aftermath of mania.
    Cookson J; Elliott B
    J Psychopharmacol; 2006 Mar; 20(2 Suppl):23-30. PubMed ID: 16551669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified.
    Greil W; Kleindienst N
    Int Clin Psychopharmacol; 1999 Sep; 14(5):283-5. PubMed ID: 10529071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bipolar switching after carbamazepine withdrawal.
    Lange-Asschenfeldt C; Blaeser I; Supprian T
    Pharmacopsychiatry; 2007 Mar; 40(2):86-7. PubMed ID: 17447183
    [No Abstract]   [Full Text] [Related]  

  • 29. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbamazepine extended-release capsules: a retrospective review of its use in children and adolescents.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():3-7. PubMed ID: 16754405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebellar ataxia in upper limbs triggered by addition of carbamazepine to lithium treatment.
    Manto MU; Jacquy J; Hildebrand J
    Acta Neurol Belg; 1996 Dec; 96(4):316-7. PubMed ID: 9008782
    [No Abstract]   [Full Text] [Related]  

  • 32. Dosing strategies and time course of response to antimanic drugs.
    Bowden CL
    J Clin Psychiatry; 1996; 57 Suppl 13():4-9; discussion 10-2. PubMed ID: 8970500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes and length of treatment with carbamazepine extended-release capsules in bipolar disorder.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():15-8. PubMed ID: 16754407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case study: carbamazepine treatment of juvenile-onset bipolar disorder.
    Woolston JL
    J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):335-8. PubMed ID: 10087696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproate in bipolar disorder: 2000 onwards.
    Bowden CL; Singh V
    Acta Psychiatr Scand Suppl; 2005; (426):13-20. PubMed ID: 15833096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended-release carbamazepine capsules : in bipolar I disorder.
    Swainston Harrison T; Keating GM
    CNS Drugs; 2005; 19(8):709-16. PubMed ID: 16097852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic and prophylactic effects of carbamazepine in bipolar disorders.
    Okuma T
    Psychiatr Clin North Am; 1983 Mar; 6(1):157-74. PubMed ID: 6351033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.